Single dose pharmacokinetics, safety and tolerability of MK-0476, a new leukotriene D4-receptor antagonist, in healthy volunteers.

Ítems similars

• Pharmacokinetic and pharmacodynamic analysis of a novel leukotriene biosynthesis inhibitor, MK-0591, in healthy volunteers.
  per: Uematsu, T, et al.
  Publicat: (1995)
• Effect of multiple doses of losartan on the pharmacokinetics of single doses of digoxin in healthy volunteers.
  per: De Smet, M, et al.
  Publicat: (1995)
• Pharmacokinetics and tolerability of oral rizatriptan in healthy male and female volunteers
  per: Lee, Y, et al.
  Publicat: (1999)
• Effects of montelukast (MK-0476); a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids
  per: Reiss, T. F., et al.
  Publicat: (1997)
• Assessment of the pharmacokinetics, safety and tolerability of maraviroc, a novel CCR5 antagonist, in healthy volunteers
  per: Abel, Samantha, et al.
  Publicat: (2008)